Impact of mold on mast cell-cytokine immune response

Journal of Biological Regulators and Homeostatic Agents

Volumn 32, Issue 4, 2018, Pages 763-768

  Kritas, S K ^a   Gallenga, C E ^b   D'Ovidio C ^c   Ronconi, G ^d   Caraffa, Al ^e   Toniato, E ^c   Lauritano, D ^f   Conti, P ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cytokine; Fungi; IL 37; Inflammation; Mast cell; Mold

Indexed keywords

CHEMOKINE; CHIMASE; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 37; MYELOID DIFFERENTIATION FACTOR 88; PROTEINASE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRYPTASE; UNCLASSIFIED DRUG; IL37 PROTEIN, HUMAN;

ANGIOGENESIS; BRONCHITIS; CELL ACTIVATION; COUGHING; FATIGUE; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MOULD; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; SINUSITIS; BIOSYNTHESIS; FUNGUS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MYCOSIS;

CYTOKINES; FUNGI; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-1; MAST CELLS; MYCOSES;

EID: 85050629719     PISSN: 0393974X     EISSN: 17246083     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Vacher G, Niculita-Hirzel H, Roger T. Immuneresponses to airborne fungi and non-invasive airway diseases. Semin Immunopathol 2015; 37(2):83-96.
2. Nazimek K, Bryniarski K, Askenase PW. Functions of exosomes and microbial extracellular vesicles in allergy and contact and delayed-type hypersensitivity. Int Arch Allergy Immunol 2016; 171(1):1-26.
3. Schwartze VU, Jacobsen ID. Mucormycoses caused by Lichtheimia species. Mycoses. 2014; 57(Suppl 3):73-8.
4. Chrenkova V, Hubka V, Cetkovsky P, et al. Proven invasive pulmonary aspergillosis in stem cell transplant recipient due to Aspergillus sublatus, a cryptic species of A. nidulans. Mycopathologia 2017; 183(2):423-429.
5. Lopes JP, Stylianou M, Nilsson G, Urban CF. Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells. Sci Rep 2015; 5:12287.
6. Kim HH, Lee S, Singh TS, Choi JK, Shin TY, Kim SH. Sparassis crispa suppresses mast cell-mediated allergic inflammation: Role of calcium, mitogen-activated protein kinase and nuclear factor-κB. Int J Mol Med 2012; 30(2):344-50.
7. Regan T, Nally K, Carmody R, Houston A, Shanahan F, Macsharry J, Brint E. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol 2013; 91(12):6084-92.
8. Taghavi M, Khosravi A, Mortaz E, Nikaein D, Athari SS. Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections. Eur J Pharmacol 2017; 808:8-13.
9. Mortaz E, Adcock IM, Tabarsi P, Darazam IA, Movassaghi M, Garssen J, Jamaati H, Velayati A. Pattern recognitions receptors in immunodeficiency disorders. Eur J Pharmacol 2017; 808:49-56.
10. LeibundGut-Landmann S, Wüthrich M, Hohl TM. Immunity to fungi. Curr Opin Immunol 2012; 24(4):449-58.
11. Pennini ME, Perkins DJ, Salazar AM, Lipsky M, Vogel SN. Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice. J Immunol 2013; 190(1):307-16.
12. Gresnigt MS, Rösler B, Jacobs CW, et al. The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses. Eur J Immunol 2013; 43(2):416-26.
13. Tang YJ, Dou HT, Zhang QH, Liu JJ, Yang XS. Expression of inflammatory cytokines in ovarian epithelial cancer and their correlation. J Biol Regul Homeost Agents 2017; 31(2):413-18.
14. Zidi S, Bediar-Boulaneb F, Belguendouz H, et al. Local pro-inflammatory cytokine and nitric oxide responses are elevated in patients with pterygium. Int J Immunopathol Pharmacol 2017; 30(4):395-405.
15. Amaral RC, Barbeiro DF, Koike MK, et al. Cytokine and chemokine levels in the heart tissue of aged rats following severe acute pancreatitis. Eur J Inflamm 2017; 15:102-6.
16. Morita H, Arae K, Unno H, et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity 2015; 43(1):175-86.
17. Ma N, Liu Q, Hou L, Wang Y, Liu Z. MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer. Int J Immunopathol Pharmacol 2017; 30(2):152-62.
18. Yang W-H, Liu Y-H, Liang J-L, et al. β-Patchoulene, isolated from patchouli oil, suppresses inflammatory mediators in LPS-stimulated RAW264.7 macrophages. Eur J Inflamm 2017; 15:136-41.
19. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013;39(6):1003-18.
20. Su C, Yang T, Wu Z, et al. Differentiation of T-helper cells in distinct phases of atopic dermatitis involves Th1/Th2 and Th17/Treg. Eur J Inflamm 2017; 15:46-52.
21. Taracanova A, Alevizos M, Karagkouni A, et al. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cellsmediated by the interaction of their receptors. Proc Natl Acad Sci U S A 2017; 114(20):E4002-E4009.
22. Theoharides TC, Stewart JM, Tsilioni I. Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion. Int J Immunopathol Pharmacol 2017; 30(2):146-151.
23. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-86.
24. Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 2003; 171(9):4830-36.
25. Galli SJ, Gaudenzio N. Human mast cells as antigen-presenting cells: When is this role important in vivo? J Allergy Clin Immunol 2017; 141(1):92-93.
26. Boraschi D, Lucchesi D, Hainzl S, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22(3):127-47.
27. Conti P, Carinci F, Lessiani G, Spinas E, Kritas SK, Ronconi G, Caraffa A, Theoharides TC. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells. Immunol Res 2017; 65(5):982-86.
28. Conti P, Caraffa A, Ronconi G, et al. Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers). Immunol Res 2018; doi: 10.1007/ s12026-018-9004-9. [Epub ahead of print].
29. Conti P, Ronconi G, Kritas SK, Caraffa A, Theoharides TC. Activated mast cells mediate low-grade inflammation in type 2 diabetes: interleukin-37 could be beneficial. Can J Diabetes 2018. doi: 10.1016/j.jcjd.2018.01.008. [Epub ahead of print].
30. Zhan Q, Zeng Q, Song R, et al. IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells. Mol Med 2017; 23. doi: 10.2119/molmed.2017.00022.